Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.21.64 (
proteinase K
)
4,071
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The type I membrane protein
calnexin
functions as a molecular chaperone for secretory glycoproteins in the endoplasmic reticulum with ATP and Ca2+ as two of the cofactors involved in substrate binding. Protease protection experiments with intact canine rough microsomes showed that amino acid residues 1-462 of
calnexin
are located within the lumen of the endoplasmic reticulum. Expression using the baculovirus Sf9 insect cell system of a recombinant truncated
calnexin
corresponding to residues 1-462 (
calnexin
delta TMC) revealed an association in vivo with a coexpressed secretory glycoprotein substrate, human immunodeficiency virus type I gp120. For the in vitro characterization of
calnexin
delta TMC, we purified this secreted form to homogeneity from the medium of Sf9 cells. We demonstrate that the properties of the purified
calnexin
delta TMC correspond to those of full-length
calnexin
in canine microsomes with at least one intramolecular disulfide bond and binding to 45Ca2+. Calnexin delta TMC underwent a marked and reversible conformational change following Ca2+ binding as measured by its resistance to
proteinase K
digestion of a 60-kDa fragment and also by the change from an oligomeric form of
calnexin
delta TMC to a monomeric form. We also found that
calnexin
bound Mg-ATP leading to a conformational change from a monomeric to an oligomeric form that coincided as with markedly increased proteinase sensitivity. Our results identify the luminal domain of
calnexin
as responsible for binding substrates, Ca2+, and Mg-ATP. Because Ca2+ and ATP are required in vivo for the maintenance of
calnexin
-substrate interactions, conformational changes in the luminal domain of
calnexin
induced by Ca2+ and Mg-ATP are relevant to the in vivo function of
calnexin
as a molecular chaperone.
...
PMID:Conformational changes induced in the endoplasmic reticulum luminal domain of calnexin by Mg-ATP and Ca2+. 762 14
The endoplasmic reticulum (ER) not only links the translational machinery to the endomembrane system in eukaryotic cells but also provides a protective environment for the folding of exoplasmic proteins translocated across the ER membrane. Here we describe that the lumenal surface of the ER membranes transiently tethers the folding intermediate of secretory proteins via a 90-kDa ER membrane protein,
calnexin
. We demonstrate that p70, the precursor to gp80, the major secretory protein in Madin-Darby canine kidney (MDCK) cells, was bound transiently to
calnexin
in the immediate post-synthetic period (0-10 min) and showed a t1/2 for dissociation from
calnexin
of 2.5 min. The bound p70 was found to be incompletely folded as assessed by susceptibility to
proteinase K
digestion. Perturbation of the redox state by 5 mM dithiothreitol or 1 mM diamide markedly inhibited the dissociation of p70 from
calnexin
(t1/2 > 30 min). Cellular depletion of ATP led to premature dissociation of p70 from
calnexin
and the formation of p70 aggregates that did not bind
calnexin
. These findings demonstrate that nascent unfolded p70 is tethered to
calnexin
during normal protein maturation, including the formation and editing of disulfide bonds and that ATP is required for the productive interaction of gp80 and
calnexin
.
...
PMID:Chaperone function of calnexin for the folding intermediate of gp80, the major secretory protein in MDCK cells. Regulation by redox state and ATP. 790 29